,date,title,stock,close,volume,1_past_close,2_past_close,3_past_close,4_past_close,5_past_close,next_close,next_volume
0,2010-01-04,"Benzingaâ€™s News Roundup (BFRM, INTC, NVS, SYT, ITMN, CHK, MS)",NVS,-0.03343764768879198,18.473140230231078,-0.0038431606934188345,-0.004191641480160713,0.0021918107301732714,,,-0.0009503230914617022,-0.4482832806703333
1,2010-01-12,"Market Round-Up (INTC, WMT, ACL, NVS, NSRGY.PK, KBH)",NVS,-0.011075657956248985,0.058187666543061844,0.017962666308779518,0.00809103597565275,-0.00878361421065843,-0.0036149764439555865,-0.0009503230914617022,0.006454195846267385,-0.02529039270992761
2,2010-01-20,"Market Round-up (C, BAC, BRK.A, XTO, XOM, ACL, NVS, AAPL, MSFT, GOOG)",NVS,-0.00316590035854758,-0.10878140267235326,0.015506789696436263,-0.01435213267312374,0.011882300481496078,0.006454195846267385,-0.011075657956248985,-0.0009340571953061483,-0.006161705529428074
3,2010-03-18,"US Stock Futures Mixed (PFE, TEVA, GSK, NKE, NVS, FDX)",NVS,0.002188819148770671,-0.23672287342075737,-0.0007290954228904578,0.001460257109442642,0.001462708851144523,-0.0007308199371768298,0.0012806201174146992,-0.00218403868307937,-0.1928028657138824
4,2010-08-09,Finally There Is A Cure For Tobacco Addiction (CIGX),NVS,0.004177371089878701,-0.29889532289846454,0.00019900784792081794,0.011267506940002558,-0.005800879037092699,-0.0027929901839058857,0.028518659239736843,0.014857597861752003,1.4246925479033998
5,2010-09-22,US Stock Futures Signals A Low Start After Federal Reserve Warning On Economic Recovery,NVS,-0.005136191942088697,0.6101659830956392,-0.003530031580096349,0.016505255036078914,0.007227963993409192,-0.008598985382981317,-0.005523025151344951,0.002670604072089855,-0.3764229946363795
6,2011-01-24,"Market Roundup (HAL, GXDX, NVS, INTC, AXP, CSX, TXN)",NVS,0.01914225525705504,-0.10232513076126781,0.003022130226215891,-0.014368299187340727,-0.006960374817437387,0.011439702656263817,-0.0036820893092794904,0.005217423280768463,-0.005057792489831736
7,2011-04-20,"Five Stocks that May End Up, umm, Higher, if Marijuana is Legalized",NVS,0.029872076286497462,-0.11146033573338732,0.03706422049735081,-0.030914911735619888,0.004487615971112469,0.00796077301642728,0.00018099755854139588,-0.014330181147263366,0.24954467031989647
8,2011-07-19,Earnings Roundup ,NVS,0.022196726858699778,0.3248539813215021,-0.011699912873791019,0.0030969863811440845,-0.004866042236924217,0.005545357623205183,-0.0026026424177356677,0.004825448389092601,-0.2727495163291699
9,2011-07-22,"Earnings Preview: Mylan Laboratories EPS, Revenue Expected to Rise from Previous Quarter",NVS,-0.010563399699243026,-0.10631545038533141,0.0001600546285858151,0.004825448389092601,0.022196726858699778,-0.011699912873791019,0.0030969863811440845,0.013749725078382236,0.004579143168636612
10,2011-10-25,What Does Novartis' Earnings Release Really Mean for the Company?,NVS,-0.04230353320636715,2.031793414269291,0.0015312937729941023,0.013625440494350105,0.02059490642384687,-0.017128057253098072,0.006968713111209723,0.011708021766893895,-0.42400645177722074
11,2011-10-25,Earnings Roundup ,NVS,-0.04230353320636715,2.031793414269291,0.0015312937729941023,0.013625440494350105,0.02059490642384687,-0.017128057253098072,0.006968713111209723,0.011708021766893895,-0.42400645177722074
12,2011-12-20,"Benzinga's M&A Chatter for Tuesday December 20, 2011",NVS,0.003568220283932666,0.7812920393571061,0.012646894731874081,-0.013545008221960475,0.0396518048721437,-0.0029559263642852107,-0.004780357554664327,0.0031999093447365734,-0.5514981935116544
13,2012-01-10,Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target?,NVS,-0.0012281320709863763,0.1541817827055718,-0.00540900576799519,-0.0026104954648435985,-0.008113258262465894,-0.00429698265945988,0.017666591331861436,-0.007728880472722688,0.17938753455308554
14,2012-01-11,How to Trade Biotechs Based on the JP Morgan Health Care Conference,NVS,-0.007728880472722688,0.17938753455308554,-0.0012281320709863763,-0.00540900576799519,-0.0026104954648435985,-0.008113258262465894,-0.00429698265945988,0.00424853651224244,-0.22408775769493894
15,2012-01-13,US Stock Futures Mixed; J.P. Morgan Earnings In Focus ,NVS,-0.016393503894358008,0.04170200486884723,0.00424853651224244,-0.007728880472722688,-0.0012281320709863763,-0.00540900576799519,-0.0026104954648435985,0.008602144919578558,-0.2512368192913764
16,2012-01-13,Stocks To Watch For January 13,NVS,-0.016393503894358008,0.04170200486884723,0.00424853651224244,-0.007728880472722688,-0.0012281320709863763,-0.00540900576799519,-0.0026104954648435985,0.008602144919578558,-0.2512368192913764
17,2012-01-25,Earnings Roundup,NVS,-0.011813041630218013,0.5009052127677778,0.002512001202260361,0.011249985722452838,-0.05520298881579566,0.01567138615793051,0.020433538227160097,-0.007426180745036315,-0.2603724469007471
18,2012-01-25,"Financial Breakfast: Morning News Summary for January 25, 2012",NVS,-0.011813041630218013,0.5009052127677778,0.002512001202260361,0.011249985722452838,-0.05520298881579566,0.01567138615793051,0.020433538227160097,-0.007426180745036315,-0.2603724469007471
19,2013-01-11,Three Stocks to Buy for Flu Season,NVS,0.003067855929469232,-0.21117414174752658,0.008664661543160035,0.00030961812913288256,0.0026381063902056745,0.002489365753928885,0.009104805328305599,0.0013764680321095568,0.3007078745257703
21,2013-03-14,Generic Drugs Will Hit Pharmaceuticals Hard in 2013,NVS,0.005101950381062981,0.9069975124671374,-0.0133754187398053,0.007827322062294195,0.004513533170669826,-0.0010180928113137089,0.0008735403558743915,0.013633090343793342,0.004053141358424384
23,2013-03-14,Generics Will Hit Drug Companies Hard in 2013,NVS,0.005101950381062981,0.9069975124671374,-0.0133754187398053,0.007827322062294195,0.004513533170669826,-0.0010180928113137089,0.0008735403558743915,0.013633090343793342,0.004053141358424384
26,2013-04-11,ETF Showdown: A Pharma Fight,NVS,0.012852475783281303,-0.16455415331817447,0.013019639296111496,-0.0018166204677240172,0.014316198528115054,-0.0067577565032954645,-0.006295490918528213,-0.0005459198825055189,-0.31065618968844777
30,2013-04-24,"Earnings Scheduled For April 24, 2013",NVS,-0.010241714064239904,0.34543388398695263,0.008538900388836534,0.0023466246309886696,0.005831797477624745,0.0022264539358975988,-0.024304031659248215,0.008416040908214129,-0.0493244825471959
34,2013-05-28,Canadian Pharma Valeant to Buy Bausch & Lomb,NVS,-0.012237842542536681,0.8011700528983989,0.007315101548094782,-0.010721088979052662,-0.00013378383169171393,0.006337494117073295,0.00013489706249902866,-0.009938590511735734,0.6700420859025786
36,2013-05-28,Valeant Pharmaceuticals to Buy Bausch & Lomb,NVS,-0.012237842542536681,0.8011700528983989,0.007315101548094782,-0.010721088979052662,-0.00013378383169171393,0.006337494117073295,0.00013489706249902866,-0.009938590511735734,0.6700420859025786
38,2013-07-02,Pfizer and Novartis Said to be Zeroing in on Onyx,NVS,-0.002963257895518656,0.5985011087175012,0.0022627507756090015,0.004118097955892797,0.011636320544584411,0.010158176174660971,0.007161647818431094,0.0008493590547364871,-0.5266059454274707
39,2013-07-02,"Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)",NVS,-0.002963257895518656,0.5985011087175012,0.0022627507756090015,0.004118097955892797,0.011636320544584411,0.010158176174660971,0.007161647818431094,0.0008493590547364871,-0.5266059454274707
42,2013-07-22,"Benzinga's M&A Chatter for Monday July 22, 2013",NVS,0.0039962618928197635,0.9404141385745854,-0.0011012899996660774,-0.003155776735670912,-0.00803059441984344,-0.00325610902804907,0.0008147942273308839,-0.0021959800440470856,-0.34384996259930556
46,2013-07-30,"Benzinga's M&A Chatter for Tuesday July 30, 2013",NVS,-0.002804225143355543,-0.3117209046099648,-0.006685199077322568,-0.005953071815849698,-0.0066016152595165245,0.00013750353424435424,-0.0021959800440470856,0.006889676087881158,1.0906356221830067
49,2013-08-15,US Stock Futures Down Ahead Of Economic Data,NVS,-0.0038033136403290424,0.17330305917484368,-0.002168679827542541,0.0077859398209265684,-0.002860172700601571,-0.00406952254350379,-0.0001355826348811151,-0.006817596529156922,-0.04786206557140771
52,2013-08-26,Amgen and Onyx Finally Ink a Deal Two Months In The Making,NVS,-0.003845168237959218,0.8445077701718673,0.009098382943906413,0.006599161390519637,-0.006423169066483547,0.025102913875211907,0.0008236871589362149,-0.011180538148642616,-0.46633542339916956
55,2013-08-26,Amgen and Onyx Finally Ink Deal Two Months In The Making,NVS,-0.003845168237959218,0.8445077701718673,0.009098382943906413,0.006599161390519637,-0.006423169066483547,0.025102913875211907,0.0008236871589362149,-0.011180538148642616,-0.46633542339916956
57,2013-09-19,Write A Prescription For Health Care ETFs,NVS,-0.007692409418869728,-0.16292958361149457,0.0199467474617534,-0.0013280442021409433,-0.011811066873113618,0.0002625245800971232,-0.003661885432261869,0.004467424992643965,-0.1407068962290996
59,2013-10-11,US Stock Futures Up; J.P. Morgan Earnings In Focus,NVS,0.01338564846258894,-0.16805227382646726,0.01370612740282473,-0.01191763559829484,-0.02003979056674554,-0.0051494123422448634,-0.0005279011948290391,0.0032020762256703694,-0.17522705595682575
62,2013-11-22,Market Wrap For November 22: Markets Finish The Week On a Positive Note,NVS,0.006820775414305702,-0.006222925874617924,0.011111053016550132,-0.002674740308843071,0.0008923237489220082,-0.009095336971540191,0.003804120934721489,-0.0022580869939570203,-0.3664345456729402
64,2014-01-24,Market Wrap For January 24: Fear Is Back In The Markets,NVS,-0.023841361698414554,-0.23054967917897795,0.012377604247026053,-0.007127772525842069,0.002340488501611615,-0.007336883672930838,0.01162807924145981,-0.013276658663946228,0.08576370601978267
65,2014-01-24,Market Wrap For January 24: Fear is Back in the Markets,NVS,-0.023841361698414554,-0.23054967917897795,0.012377604247026053,-0.007127772525842069,0.002340488501611615,-0.007336883672930838,0.01162807924145981,-0.013276658663946228,0.08576370601978267
68,2014-01-29,"Market Wrap For January 29: Markets Lower on Fed Taper, Emerging Markets Worries",NVS,-0.0036450801977548908,0.9643136567941046,0.00990094402257613,-0.013276658663946228,-0.023841361698414554,0.012377604247026053,-0.007127772525842069,0.008452179867838971,-0.3399184759463122
72,2014-02-03,Market Wrap For January 3: Bears In Complete and Absolute Control,NVS,-0.005691103779705831,-0.23062986620377246,-0.010883182547038683,0.008452179867838971,-0.0036450801977548908,0.00990094402257613,-0.013276658663946228,-0.00534222883566271,0.5263158377646093
74,2014-02-03,Market Wrap For February 3: Bears In Complete and Absolute Control,NVS,-0.005691103779705831,-0.23062986620377246,-0.010883182547038683,0.008452179867838971,-0.0036450801977548908,0.00990094402257613,-0.013276658663946228,-0.00534222883566271,0.5263158377646093
78,2014-02-04,Market Wrap for February 4: Investors and Traders Go Bargain Hunting,NVS,-0.00534222883566271,0.5263158377646093,-0.005691103779705831,-0.010883182547038683,0.008452179867838971,-0.0036450801977548908,0.00990094402257613,0.004475859099749346,-0.4187911160110598
80,2014-02-04,Market Wrap For February 4: Investors And Traders Go Bargain Hunting,NVS,-0.00534222883566271,0.5263158377646093,-0.005691103779705831,-0.010883182547038683,0.008452179867838971,-0.0036450801977548908,0.00990094402257613,0.004475859099749346,-0.4187911160110598
82,2014-02-19,"Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends Winning Streak",NVS,-0.011605423718997976,0.7343934123143152,-0.0026523303405904253,0.008021186846919992,0.0050079810499787936,0.012490514475503645,0.003226120209689043,0.006360098204783116,-0.11164147628892385
83,2014-02-19,"Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends its Winning Streak",NVS,-0.011605423718997976,0.7343934123143152,-0.0026523303405904253,0.008021186846919992,0.0050079810499787936,0.012490514475503645,0.003226120209689043,0.006360098204783116,-0.11164147628892385
87,2014-02-26,Market Wrap For February 26: Markets Slightly Higher On Housing Data,NVS,-0.0046540621216815126,-0.35837050945421256,0.0033524164204097318,0.010526409175038332,0.0044967540894418345,0.006360098204783116,-0.011605423718997976,0.023038548440538653,0.4726717737671444
88,2014-02-26,Market Wrap For February 26: Markets Slightly Higher on Housing Data,NVS,-0.0046540621216815126,-0.35837050945421256,0.0033524164204097318,0.010526409175038332,0.0044967540894418345,0.006360098204783116,-0.011605423718997976,0.023038548440538653,0.4726717737671444
91,2014-03-07,Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains,NVS,-0.008112421573425066,-0.06138466919826435,0.008664351810028226,0.006418575482585176,0.01574639164582603,-0.022722036562141668,0.007631863754404389,-0.0028868927999667893,-0.1539885272867153
92,2014-03-07,Market Wrap For March 7: Markets Cap off Positive Week with Small Gains,NVS,-0.008112421573425066,-0.06138466919826435,0.008664351810028226,0.006418575482585176,0.01574639164582603,-0.022722036562141668,0.007631863754404389,-0.0028868927999667893,-0.1539885272867153
96,2014-03-18,Market Wrap For March 18: Markets Positive Despite Crimea Concerns,NVS,0.005964828408286715,1.282628972407918,0.006863642689789895,-0.000857210839192879,-0.013291585783586468,-0.0004831007888742578,-0.0012061882390942413,-0.01730398683524792,-0.10532308280083946
100,2014-03-24,Google Honors Activist Dorothy Height and Her Contributions,NVS,-0.005260945500539127,-0.38208397293191987,0.0051653315387361065,0.0012312163981282875,-0.01730398683524792,0.005964828408286715,0.006863642689789895,0.007010854992034021,0.7368227240691712
102,2014-03-24,Google Honors Activist Dorothy Height & Her Contributions,NVS,-0.005260945500539127,-0.38208397293191987,0.0051653315387361065,0.0012312163981282875,-0.01730398683524792,0.005964828408286715,0.006863642689789895,0.007010854992034021,0.7368227240691712
104,2014-03-25,Market Wrap For March 25: Markets Snap Two-Day Losing Steak On Confidence Data,NVS,0.007010854992034021,0.7368227240691712,-0.005260945500539127,0.0051653315387361065,0.0012312163981282875,-0.01730398683524792,0.005964828408286715,-0.00928282307336914,-0.3854268172248947
105,2014-03-25,Market Wrap For March 25: Markets Snap Two-Day Losing Steak on Confidence Data,NVS,0.007010854992034021,0.7368227240691712,-0.005260945500539127,0.0051653315387361065,0.0012312163981282875,-0.01730398683524792,0.005964828408286715,-0.00928282307336914,-0.3854268172248947
108,2014-03-27,Market Wrap For March 27: Markets Lower Following Mixed Economic Data,NVS,0.0032054736757105573,-0.07674668681259267,-0.00928282307336914,0.007010854992034021,-0.005260945500539127,0.0051653315387361065,0.0012312163981282875,0.0027035679672817725,-0.1748140534895749
112,2014-04-22,US Stock Futures Edge Higher Ahead Of McDonald's Earnings,NVS,0.012871309180486179,0.4321925524736405,0.009330358327201305,0.0030803667812271396,0.007399413625782447,-0.0004770946276930754,0.014031452860572058,-0.004505476555077825,-0.14490879610526863
115,2014-04-22,"Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive",NVS,0.012871309180486179,0.4321925524736405,0.009330358327201305,0.0030803667812271396,0.007399413625782447,-0.0004770946276930754,0.014031452860572058,-0.004505476555077825,-0.14490879610526863
116,2014-04-22,"Market Wrap For April 22: S&P Rises for Sixth Straight Day, Dow and Nasdaq Also Positive",NVS,0.012871309180486179,0.4321925524736405,0.009330358327201305,0.0030803667812271396,0.007399413625782447,-0.0004770946276930754,0.014031452860572058,-0.004505476555077825,-0.14490879610526863
119,2014-04-24,Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns,NVS,-0.018335746178229306,0.3814602849732003,-0.004505476555077825,0.012871309180486179,0.009330358327201305,0.0030803667812271396,0.007399413625782447,-0.0014186338935053833,-0.4364484089612073
120,2014-04-24,"Earnings Scheduled For April 24, 2014",NVS,-0.018335746178229306,0.3814602849732003,-0.004505476555077825,0.012871309180486179,0.009330358327201305,0.0030803667812271396,0.007399413625782447,-0.0014186338935053833,-0.4364484089612073
126,2014-07-11,Benzinga Weekly Preview: Earnings Season Kicks Into High Gear,NVS,-0.00322905002414553,0.06926674258536658,-0.00288659931837032,0.006143844702115819,-0.008527990790416773,-0.012468690564440665,-0.0006556601731672052,0.008154573121187836,-0.31243184616860453
130,2014-07-15,"Markets Mixed, NASDAQ Lower As Yellen Suggests Valuations Are Stretched",NVS,-0.0012189084998596167,0.6380689340983186,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.006143844702115819,-0.008527990790416773,-0.0011093078773974918,-0.18195961049751608
131,2014-07-15,"Markets Mixed, Nasdaq Lower As Yellen Suggests Valuations Are Stretched",NVS,-0.0012189084998596167,0.6380689340983186,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.006143844702115819,-0.008527990790416773,-0.0011093078773974918,-0.18195961049751608
136,2014-07-17,Markets Sell-Off After Malaysian Airline Crash In Ukraine,NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
139,2014-07-17,Markets Sell-Off After Malaysian Airline Crash In Ukraine.,NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
141,2014-07-17,"#PreMarket Primer: Thursday, July 17: Russia Hit With New Sanctions",NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
145,2014-07-17,"Earnings Scheduled For July 17, 2014",NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
150,2014-07-17,"Back To Square One For Big Pharma, Following The Latest String of Alzheimer's Test Failures",NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
153,2014-07-17,"Falling Alzheimer's Rates Are Reported, But Big Pharma's Search For a Cure Yields No Results",NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
154,2014-07-17,"Falling Alzheimer's Rates Are Reported, But Pharma's Search For a Cure Yields No Results",NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
156,2014-07-17,"Alzheimer's Rates Falling, But Pharma's Search For a Cure Yields No Results",NVS,-0.01677029341464864,1.697890216460519,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.00288659931837032,0.003275736852166533,-0.32737090573714644
159,2014-07-18,"#PreMarket Primer: Friday, July 18: Tension Between Russia And The West At An All Time High",NVS,0.003275736852166533,-0.32737090573714644,-0.01677029341464864,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.0025896051223215366,-0.3220513829317615
164,2014-07-18,New Medical Technology For Diabetics,NVS,0.003275736852166533,-0.32737090573714644,-0.01677029341464864,-0.0011093078773974918,-0.0012189084998596167,0.008154573121187836,-0.00322905002414553,-0.0025896051223215366,-0.3220513829317615
167,2014-10-28,"Markets Continue To Rally As The Dow Closes Above 17,000",NVS,0.0237221145257136,1.2895502712681037,0.0006657338655269296,0.010197063700847053,0.011791538262231782,-0.004627187003450328,0.008077360063294403,-0.01126127063182103,-0.4860077222385908
172,2014-12-02,These Two Dodge & Cox Funds Are Big Hewlett-Packard Owners,NVS,-0.004253586903801954,1.92727252613752,-0.0026899557229447257,0.011406241755490099,0.005471358168618545,0.0028490405219674386,-0.0022110485586765982,-0.0033341520339331687,-0.366957874445461
177,2014-12-16,Morning Market Movers,NVS,0.00010914082113755441,0.1466682751096937,-0.02010258676644494,-0.00869203381448147,0.0010612973883867838,-0.0010601722303673622,-0.014931623673656191,0.006983024843144836,0.5102455548360496
178,2014-12-16,US Stock Futures Edge Lower; Crude Oil Drops,NVS,0.00010914082113755441,0.1466682751096937,-0.02010258676644494,-0.00869203381448147,0.0010612973883867838,-0.0010601722303673622,-0.014931623673656191,0.006983024843144836,0.5102455548360496
180,2014-12-16,Benzinga's Top #PreMarket Gainers,NVS,0.00010914082113755441,0.1466682751096937,-0.02010258676644494,-0.00869203381448147,0.0010612973883867838,-0.0010601722303673622,-0.014931623673656191,0.006983024843144836,0.5102455548360496
188,2015-01-27,"Earnings Scheduled For January 27, 2015",NVS,0.025287582779235596,-0.3213451342552237,-0.0039230089733285345,0.0003098409287902726,-0.019341760707321853,-0.026902017526078237,0.0052502954696527215,-0.018396567051258916,-0.36630052766810517
191,2015-02-25,"Benzinga's M&A Chatter for Wednesday February 25, 2015",NVS,-9.731947611490988e-05,-0.39639963928189814,-0.003398165064324221,0.003898477573815562,0.003423206325792183,0.000782907665378918,-0.0007822952004697958,0.003507412780016539,-0.09057247421099501
194,2015-02-25,News-Heavy Day For Several Biotech Stocks,NVS,-9.731947611490988e-05,-0.39639963928189814,-0.003398165064324221,0.003898477573815562,0.003423206325792183,0.000782907665378918,-0.0007822952004697958,0.003507412780016539,-0.09057247421099501
196,2015-03-04,Report: Pharmacyclics Inc. To Be Acquired By Johnson & Johnson,NVS,-0.00020183126766748494,-0.001810879811053323,-0.010092881903355222,0.004890437641003054,-0.005825294647861301,0.003507412780016539,-9.731947611490988e-05,-0.0009089464358910115,0.1817182764937355
200,2015-03-09,Analyst: 'Mess Continues' With Amgen Neupogen Competitor,NVS,0.005438164545441548,-0.048713002388998006,-0.015058085485931128,-0.0009089464358910115,-0.00020183126766748494,-0.010092881903355222,0.004890437641003054,-0.018267073720174998,1.2867954103126307
201,2015-03-09,Analyst: 'Mess Continues' With Amgen Inc. Neupogen Competitor,NVS,0.005438164545441548,-0.048713002388998006,-0.015058085485931128,-0.0009089464358910115,-0.00020183126766748494,-0.010092881903355222,0.004890437641003054,-0.018267073720174998,1.2867954103126307
204,2015-04-17,It's A Big Weekend For Biotech,NVS,-0.008227788654236345,0.32453394526563173,0.0008722493820128019,-0.00019410491242444206,0.008794348932605889,-0.011971580773677881,0.009846992693078427,-0.002147032569611129,-0.007151755175517582
206,2015-04-20,CAR-T Therapy Stocks Hit Hard Following AACR Data,NVS,-0.002147032569611129,-0.007151755175517582,-0.008227788654236345,0.0008722493820128019,-0.00019410491242444206,0.008794348932605889,-0.011971580773677881,0.017898836360291437,0.24807770133549178
211,2015-08-17,Benzinga's Top #PreMarket Gainers,NVS,0.007903898502688467,0.025597964467077183,0.0032307728497127375,0.0009798140505132835,-0.0004898359601303026,-0.008737662832858373,0.007728941387783239,-0.0006779809680023119,-0.07932670428195343
214,2015-09-04,US Stock Futures Tumble; Jobs Report In Focus,NVS,-0.008494279436643604,0.04981695994047053,-0.0025104139576346274,0.009716893180658381,-0.026125922636592747,-0.011489707227385515,-0.002940121640029547,0.017874205632068874,-0.39785443001424736
220,2015-10-02,US Stock Futures Up; All Eyes On Jobs Report,NVS,0.014907534590826055,-0.004574146921599076,-0.0002176338312041004,0.026809672822175612,-0.0034507217379406985,-0.016208716595255357,-0.005337684185610092,0.009971092147101679,0.020446101091262436
224,2015-10-02,FDA Accepts Novartis/Sandoz Regulatory Submission for Proposed Biosimilar to Enbrel,NVS,0.014907534590826055,-0.004574146921599076,-0.0002176338312041004,0.026809672822175612,-0.0034507217379406985,-0.016208716595255357,-0.005337684185610092,0.009971092147101679,0.020446101091262436
225,2015-10-27,"Earnings Scheduled For October 27, 2015",NVS,-0.023402080122618796,0.5103941735636426,-0.007313338759551646,0.005950539953754275,0.009171169706682969,-0.008014702004789931,-0.019018234193085126,0.010095459237148718,-0.10683722934863005
228,2015-12-31,A New ETF Avenue To Europe,NVS,-0.017022640680193657,-0.34306453872820875,-0.005905877059304121,0.014985753902096333,0.0032381136372596764,-0.001962291361817581,0.02109614308833274,-0.0033706166332971854,1.1937811758230419
230,2015-12-31,A New ETF Avenue to Europe,NVS,-0.017022640680193657,-0.34306453872820875,-0.005905877059304121,0.014985753902096333,0.0032381136372596764,-0.001962291361817581,0.02109614308833274,-0.0033706166332971854,1.1937811758230419
234,2016-01-27,Earnings Recap For January 27,NVS,-0.05384820001449653,0.7653266215461543,0.01249704192021639,-0.007538801916812332,0.029802118219431017,-0.00782712085879067,-0.006173624211049278,-0.021102470458710165,-0.2664674105034195
240,2016-01-27,"Earnings Scheduled For January 27, 2016",NVS,-0.05384820001449653,0.7653266215461543,0.01249704192021639,-0.007538801916812332,0.029802118219431017,-0.00782712085879067,-0.006173624211049278,-0.021102470458710165,-0.2664674105034195
243,2016-04-21,"Earnings Scheduled For April 21, 2016",NVS,-0.004047387067274144,-0.08520529472302074,-0.0048076898881855845,0.008649827872906801,0.008592501553652543,-0.005782734677589163,0.008482398015791981,0.002621770523813627,1.3958813162940715
246,2016-04-22,The Market In 5 Minutes: Sometimes It Snows In April,NVS,0.002621770523813627,1.3958813162940715,-0.004047387067274144,-0.0048076898881855845,0.008649827872906801,0.008592501553652543,-0.005782734677589163,0.0002614553091560001,0.09073544297004665
251,2016-05-03,"Benzinga's M&A Chatter for Tuesday May 3, 2016",NVS,-0.00950035196622967,-0.4729451993999805,0.011451913905845545,-0.010936033313852844,-0.0022082948770850708,0.0011704190596752984,0.005098130772174914,-0.02338715176582784,0.02048557942693252
254,2016-05-05,"Benzinga's M&A Chatter for Thursday May 5, 2016",NVS,-0.0028252835146511668,-0.2899304409531982,-0.02338715176582784,-0.00950035196622967,0.011451913905845545,-0.010936033313852844,-0.0022082948770850708,-0.014436072601754502,0.43113773498848107
257,2016-05-11,Jefferies Updates Price Targets And Sees 'Rich Catalyst Environment' Ahead For Global Pharma,NVS,-0.002389851801714471,-0.1643594283481592,0.011006794469777148,0.019849412711392178,-0.014436072601754502,-0.0028252835146511668,-0.02338715176582784,-0.003460269527250426,-0.05329754366730288
259,2016-06-03,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",NVS,0.002973509747182135,-0.554264502542213,0.013562584687117019,0.0015092978845612226,-0.007489692271384296,-0.0003744790071169568,0.003003861642872252,0.004447348876464696,-0.18522379771662445
262,2016-06-06,4 Key Takeaways From ASCO,NVS,0.004447348876464696,-0.18522379771662445,0.002973509747182135,0.013562584687117019,0.0015092978845612226,-0.007489692271384296,-0.0003744790071169568,0.0036896805917370212,0.6333682643824798
263,2016-06-06,Piper Jaffray's Takeaways From ASCO,NVS,0.004447348876464696,-0.18522379771662445,0.002973509747182135,0.013562584687117019,0.0015092978845612226,-0.007489692271384296,-0.0003744790071169568,0.0036896805917370212,0.6333682643824798
266,2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",NVS,-0.02039532666411492,0.5561605138063281,-0.019500797024533334,-0.010812003230446732,-0.002695832615527083,0.0036896805917370212,0.004447348876464696,-0.008405399615662446,-0.2280719320567518
267,2016-06-13,"Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Says Reuters",NVS,-0.02039532666411492,0.5561605138063281,-0.019500797024533334,-0.010812003230446732,-0.002695832615527083,0.0036896805917370212,0.004447348876464696,-0.008405399615662446,-0.2280719320567518
271,2016-06-29,Regeneron Is 'One Of The Stronger Growers In Biotech',NVS,0.019977310644719637,0.570952979355106,0.030424661448563928,0.0018159720283614789,-0.04425438536627557,0.012043741102915062,0.0031462508059900696,0.016383286167809707,-0.32906905521562135
275,2016-07-19,"Earnings Scheduled For July 19, 2016",NVS,-0.006216549107102787,0.009574690260491625,0.00526895172769426,-0.004998549302238309,-0.00012208520724565908,0.00428492415387538,-0.007653910574774603,0.018275516219744548,0.001123216704787433
278,2016-08-08,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients,NVS,-0.010105698624855441,-0.33380886178675784,0.0026537495851117754,0.006067784332418835,-0.006750058941048631,-0.0013242592071216475,-0.0022819619543200664,0.004375324501272537,0.004846445064868421
280,2016-08-08,Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest - Terminal Patients,NVS,-0.010105698624855441,-0.33380886178675784,0.0026537495851117754,0.006067784332418835,-0.006750058941048631,-0.0013242592071216475,-0.0022819619543200664,0.004375324501272537,0.004846445064868421
284,2016-09-26,"The Market In 5 Minutes: Oil, Debates And Epidiolex",NVS,-0.009204615929845783,0.2115015480279696,-0.006704838641465538,0.006256203959199125,0.005674795024325885,0.014010476486184142,0.007562380169563454,0.0018579570614465357,0.18938559867567428
285,2016-10-25,6 Big Pharma Companies Left To Report September Quarterly Figures,NVS,-0.03737586417133931,0.4296875,-0.0011912628807496661,-0.005005386104746212,0.0035691772000667754,-0.008648986488813515,0.009658587072928215,-0.02065248351864002,-0.48107003030560813
286,2016-10-25,"Earnings Scheduled For October 25, 2016",NVS,-0.03737586417133931,0.4296875,-0.0011912628807496661,-0.005005386104746212,0.0035691772000667754,-0.008648986488813515,0.009658587072928215,-0.02065248351864002,-0.48107003030560813
287,2016-11-09,Biotech Is Getting A Big Boost Following Clinton's Loss,NVS,0.04222790887110239,2.4157103024015654,0.005359788096355622,0.009252519365344325,0.004719629836429595,-0.018804285237769558,-0.0012614518025299004,-0.002961386019818102,-0.286073263140995
288,2016-12-19,Jefferies' 2017 Global Pharma Outlook,NVS,-0.002089619702934642,-0.16883342632786946,0.010132175809383526,0.0016916306128906822,-0.003931567863303509,0.02563366242359222,-0.00430148884447612,0.004606959720965476,-0.07421805064112719
289,2016-12-23,6 Worst Biotech Stocks Of 2016,NVS,0.0011145315502165687,-0.38492410165732605,0.003635919936411547,-0.0062534085997785205,0.004606959720965476,-0.002089619702934642,0.010132175809383526,0.002644344687815714,0.27650912776310266
290,2017-01-06,15 Biggest Mid-Day Gainers For Friday,NVS,-0.007830472697550661,0.0658050493167377,0.01996702169418474,-0.002883472827171607,-0.0001373363955501361,0.005521880532764589,0.011449324592365473,0.009252962905632156,-0.2032075516117704
291,2017-01-06,18 Stocks Moving In Friday's Pre-Market Session,NVS,-0.007830472697550661,0.0658050493167377,0.01996702169418474,-0.002883472827171607,-0.0001373363955501361,0.005521880532764589,0.011449324592365473,0.009252962905632156,-0.2032075516117704
292,2017-01-09,The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know,NVS,0.009252962905632156,-0.2032075516117704,-0.007830472697550661,0.01996702169418474,-0.002883472827171607,-0.0001373363955501361,0.005521880532764589,-0.0008090185161921948,-0.27086609859525124
293,2017-01-25,"Earnings Scheduled For January 25, 2017",NVS,0.030415612431744732,0.5889820343994792,-0.0015683018283286776,-0.007218686212422942,0.0031236097399180984,-0.020308771085108868,-0.0013890416427352337,-0.003464614504608443,-0.24492627266475864
294,2017-01-27,A CEO Who's Who Of Trump's Manufacturing Council,NVS,0.004171837863083283,-0.07314080632865794,-0.003464614504608443,0.030415612431744732,-0.0015683018283286776,-0.007218686212422942,0.0031236097399180984,0.0012463517813727787,-0.09492472330930479
295,2017-01-31,"President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'",NVS,0.022406711911911126,-0.14551004861187644,0.0012463517813727787,0.004171837863083283,-0.003464614504608443,0.030415612431744732,-0.0015683018283286776,-0.006764023333024949,0.5202046010936316
296,2017-02-15,Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers,NVS,0.008914197308154126,0.01798310152146798,-0.0035794399399274868,0.002925161204985205,0.0011980704481038273,0.006970559929178277,0.006204537725408743,0.011868602405868955,-0.2035650855113078
297,2017-02-21,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,NVS,-0.0020726365249599255,0.09282815008683465,0.006125479194159844,0.011868602405868955,0.008914197308154126,-0.0035794399399274868,0.002925161204985205,-0.002466201675241808,0.021447539985692154
298,2017-02-23,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market',NVS,0.007807407349810003,-0.11279677468866989,-0.002466201675241808,-0.0020726365249599255,0.006125479194159844,0.011868602405868955,0.008914197308154126,-0.002194822482131875,-0.221803895226929
299,2017-03-10,How The Ultra-Wealthy Are Helping Advance Health And Life Sciences,NVS,0.006523799589956969,-0.03432898466562784,0.011446267181029146,-0.0014791851316554583,-0.01561871761602196,-0.004873573771035922,0.014566370215413516,0.0001322642969725507,-0.24505782590781677
300,2017-04-05,The Market In 5 Minutes,NVS,-0.013374465542956515,0.4394872059219721,0.00497314129140225,0.0017503705996968488,-0.0065544120241961545,-0.0012023062712072097,0.0002673219371573943,-0.0008131998171693189,-0.4330794661492028
301,2017-04-20,What Would A $5.8 Billion NIH Cut Look Like? Devastation.,NVS,0.012097992868863594,1.7836660998514802,-0.00260524410236862,-0.005454855856961038,0.0024607876286562025,-0.01162025161414626,0.000676274494829654,-0.0029884358822021007,-0.4095684824336372
302,2017-04-25,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,NVS,0.021846936352920343,0.1985832604440252,0.016485045471849258,-0.0029884358822021007,0.012097992868863594,-0.00260524410236862,-0.005454855856961038,0.0014428340130980821,-0.48049399470651843
303,2017-04-25,"Earnings Scheduled For April 25, 2017",NVS,0.021846936352920343,0.1985832604440252,0.016485045471849258,-0.0029884358822021007,0.012097992868863594,-0.00260524410236862,-0.005454855856961038,0.0014428340130980821,-0.48049399470651843
304,2017-05-23,The Current State Of The Breast Cancer Treatment Space,NVS,-0.0028293418020507444,-0.5784373163489043,0.010818249034878047,0.004245740276586751,0.002754594974732516,-0.01236703040738607,0.003474854131189975,0.004194607390609839,-0.0992821207339446
305,2017-05-30,Monday's Market In 5 Minutes,NVS,-0.0012403300537275896,-0.2304631644068138,-0.008850576160918666,-0.0006143313864968025,0.004194607390609839,-0.0028293418020507444,0.010818249034878047,0.015397919918485936,0.27469492247658867
306,2017-06-12,Pegfilgrastim To Help Chemotherapy Patients Fails To Clear Regulatory Hurdle; Coherus Receives CRL,NVS,-0.003697273601207307,-0.14469350375921552,0.0011103346021679172,-0.002093106014465551,-0.007575658739320201,0.00012212930884203388,-0.0048641369588061645,0.007545811402064784,-0.024499413825188276
307,2017-06-26,Attention To Details: Neos' ADHD Portfolio,NVS,-0.006833445795773163,0.34589687620435083,0.0,0.0457848154862579,0.011764855202813784,0.0019645411112789724,0.0075468784561238955,-0.005131148476889114,-0.11380620789752083
308,2017-07-05,The Market In 5 Minutes,NVS,-0.005502855849471522,1.8834990522672284,0.0014375885301451952,-0.008552081987165838,-0.012433940016523648,-0.0007035099715748672,-0.005131148476889114,-0.013954059480104863,-0.048128916870398
309,2017-07-18,"Earnings Scheduled For July 18, 2017",NVS,0.018013623759837172,0.6307033211071165,0.0013229641226868427,0.007389308150964391,-0.007931667058993175,0.014879750508953515,-0.0013397847266881646,0.0030670604347124986,-0.346174143370506
310,2017-08-07,"Wall Street's M&A Chatter From August 4-7: Acadia Pharma, United Technologies-Rockwell Collins, United Therapeutics",NVS,-0.006237487186785073,0.31909054704753625,0.0011782389809085192,-0.004690910477393451,-0.0008204313235486982,0.001643308452492942,0.005309930290904985,-0.003315945189793057,-0.23723054459222825
311,2017-10-10,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,NVS,0.0033937067856080194,0.2467946307637765,-0.0037308516095163613,0.0015179825861197926,-0.004995958375986653,-0.006693539731748244,0.0035904095065253383,0.007581060940073936,0.1978697173763191
312,2017-10-23,8 Firms To Debut On The Markets This Week,NVS,0.0019828874928964346,1.0986335201611817,-0.004874747902468557,0.0013948341869143288,-0.00347472148774175,-0.00034731438027402195,0.002786381009617811,-0.0323594636751835,0.6360942999564116
313,2017-10-24,"Earnings Scheduled For October 24, 2017",NVS,-0.0323594636751835,0.6360942999564116,0.0019828874928964346,-0.004874747902468557,0.0013948341869143288,-0.00347472148774175,-0.00034731438027402195,-0.021171656522295912,-0.39983911967273844
314,2017-11-06,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",NVS,-0.002389481916846292,0.04805346863108606,0.011113657801132826,0.00012093582268057901,0.002300804712751514,0.010276493819277865,0.012636163156636071,-0.013293475263558618,2.854770910871893
315,2017-12-04,Eli Lilly's Taltz Gets Approval For Label Expansion in US,NVS,-0.01359674763518437,-0.1533043592622635,0.0029137628488609124,0.0076337150932785924,-0.0025769943424814867,0.010056852968479912,-0.0065821912693836415,-0.012252593317151561,0.019639637698335655
316,2017-12-20,3 Biotech Pipeline Areas To Keep An Eye On In 2018,NVS,-0.019827639056811508,0.23627203826372667,-0.00399669505631528,0.0024746501857748626,0.004616961335129233,-0.0022441505661833228,0.0023677905644368114,0.005298157559457284,-0.21193769757544767
317,2018-02-08,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,NVS,-0.026880388195207106,-0.14438298522150772,-0.016351577552609964,0.01650362766780855,-0.04027601222289112,-0.023854101211680523,0.005440667898861884,0.00860176608114438,0.21010423380100152
318,2018-04-03,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,NVS,0.006659073502877977,0.3224975066407292,-0.015584331369778659,-0.004923057458974922,0.0226557661709621,-0.002886555772768973,0.014256548649088208,0.009610556886239463,0.3233731130586157
319,2018-04-09,31 Stocks Moving In Monday's Mid-Day Session,NVS,0.010847767730920443,0.6508558868456955,-0.010609235268588368,0.0021014630976026183,0.009610556886239463,0.006659073502877977,-0.015584331369778659,0.009867976789691202,-0.5461532077350817
320,2018-04-09,20 Stocks Moving In Monday's Pre-Market Session,NVS,0.010847767730920443,0.6508558868456955,-0.010609235268588368,0.0021014630976026183,0.009610556886239463,0.006659073502877977,-0.015584331369778659,0.009867976789691202,-0.5461532077350817
321,2018-04-09,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,NVS,0.010847767730920443,0.6508558868456955,-0.010609235268588368,0.0021014630976026183,0.009610556886239463,0.006659073502877977,-0.015584331369778659,0.009867976789691202,-0.5461532077350817
322,2018-04-10,40 Biggest Movers From Yesterday,NVS,0.009867976789691202,-0.5461532077350817,0.010847767730920443,-0.010609235268588368,0.0021014630976026183,0.009610556886239463,0.006659073502877977,-0.011725823874294439,-0.12531496240683415
323,2018-04-19,"10 Stocks To Watch For April 19, 2018",NVS,-0.033047809764474856,0.3516654860500106,-0.0009783059167324248,0.00751530260499278,0.0016039856119185458,-0.004911571912327162,0.006550498935142812,-0.01417714716082541,-0.5069610954342608
324,2018-04-19,"Earnings Scheduled For April 19, 2018",NVS,-0.033047809764474856,0.3516654860500106,-0.0009783059167324248,0.00751530260499278,0.0016039856119185458,-0.004911571912327162,0.006550498935142812,-0.01417714716082541,-0.5069610954342608
325,2018-05-01,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Action Dates,NVS,-0.005346062328173917,0.43262824929095256,-0.007506181113970833,0.0007771417472262065,0.01033748054583139,-0.007403441436006908,-0.007860977085843768,-0.006423910872726424,0.09616549993500634
326,2018-05-01,"Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings",NVS,-0.005346062328173917,0.43262824929095256,-0.007506181113970833,0.0007771417472262065,0.01033748054583139,-0.007403441436006908,-0.007860977085843768,-0.006423910872726424,0.09616549993500634
327,2018-05-02,Esperion Shares Plunge After Cholesterol-Lowering Drug's Phase 3 Results Stir Safety Concerns,NVS,-0.006423910872726424,0.09616549993500634,-0.005346062328173917,-0.007506181113970833,0.0007771417472262065,0.01033748054583139,-0.007403441436006908,0.006993223202157672,0.1460080770425598
328,2018-05-14,"The Week Ahead: Coindesk Conference, Walmart And Retailers Close Out Earnings Season",NVS,0.010058017805125496,-0.39429250462439414,0.007928276958892644,-0.001945911828175051,-0.0006481945788127108,0.0006486150075444286,0.0052159178873192324,-0.011234490131917463,0.4026254149970139
329,2018-05-17,"Benzinga's Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More",NVS,-0.005799169582754615,0.5815818262854364,0.0019368670961934509,-0.011234490131917463,0.010058017805125496,0.007928276958892644,-0.001945911828175051,-0.0011664523653670544,-0.2952923906443875
330,2018-05-18,"Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved",NVS,-0.0011664523653670544,-0.2952923906443875,-0.005799169582754615,0.0019368670961934509,-0.011234490131917463,0.010058017805125496,0.007928276958892644,-0.0035037110225013546,-0.33261191479667385
331,2018-05-25,Novartis Gets Approval For Remicade Biosimilar In Europe,NVS,-0.0009189883258327036,-0.23162455004524096,-0.003401869579546357,-0.005335693254406304,0.0006510148575178398,-0.0035037110225013546,-0.0011664523653670544,-0.014980254233302182,0.35947750322898986
332,2018-05-29,"The Market In 5 Minutes: Italy, ASCO, Roku And More",NVS,-0.014980254233302182,0.35947750322898986,-0.0009189883258327036,-0.003401869579546357,-0.005335693254406304,0.0006510148575178398,-0.0035037110225013546,0.010272185361850816,0.13031548184133857
333,2018-05-30,"Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",NVS,0.010272185361850816,0.13031548184133857,-0.014980254233302182,-0.0009189883258327036,-0.003401869579546357,-0.005335693254406304,0.0006510148575178398,-0.015977838985546278,0.6013703125389802
334,2018-06-08,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",NVS,-0.0037091333750984834,0.08399430427846011,0.0037229422645053134,0.004138871466154992,-0.01135163586828436,0.002116352736809768,0.014492813718400388,0.007844754081342886,0.8325790692737567
335,2018-06-28,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",NVS,0.007730533770617498,-0.0757008753322117,-0.016295428786989308,-0.00526823371732188,-0.01372239161074651,0.014598601121703414,-0.0033678887147386982,0.034794514826752554,1.3137662800844563
336,2018-06-29,"Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos",NVS,0.034794514826752554,1.3137662800844563,0.007730533770617498,-0.016295428786989308,-0.00526823371732188,-0.01372239161074651,0.014598601121703414,-0.010987569546671017,-0.5690255145027585
337,2018-07-05,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,NVS,0.019878019275452408,1.223860994234066,0.010038889659415018,-0.010987569546671017,0.034794514826752554,0.007730533770617498,-0.016295428786989308,0.0027287314266319918,-0.5792042838535061
338,2018-07-09,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,NVS,0.004276328017142728,-0.1602731869524121,0.0027287314266319918,0.019878019275452408,0.010038889659415018,-0.010987569546671017,0.034794514826752554,-0.0027098509751416477,0.32577893345729203
339,2018-07-18,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Cocktail Clears FDA Hurdle, Cara To Offer Shares",NVS,0.02871660564382794,0.2355239793332531,0.0013996651917507208,-0.002411719445092775,-0.0020268087818420266,0.033922672780789975,-0.012161864115967536,-0.0019762385730319743,0.2651580591002951
340,2018-07-18,"Earnings Scheduled For July 18, 2018",NVS,0.02871660564382794,0.2355239793332531,0.0013996651917507208,-0.002411719445092775,-0.0020268087818420266,0.033922672780789975,-0.012161864115967536,-0.0019762385730319743,0.2651580591002951
341,2018-09-06,New Class of Migraine Drug Creates Four-Way Pharma Development Race,NVS,-0.006821010604564415,0.12365224899351479,-0.005571661558317342,-0.005421097131438679,-0.005749242144232225,-0.002151235486238967,-0.0016704291879725552,0.0029434301562671905,-0.17405925413741785
342,2018-09-17,Teva's Preventive Migraine Treatment Approved By FDA,NVS,-0.001055933472263182,0.8505771836608285,-0.0009380557763122299,0.010304594100529307,0.00547798092946028,0.01744810429524346,0.009171011841626386,-0.0011747147045811923,-0.23878803015875494
343,2018-10-03,"The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",NVS,0.012856070124040553,0.1950007742184774,0.0001159698542807508,0.0019729863217319288,0.0005807326309956728,-0.003471881177544267,0.005937053811913229,-0.01829627385654986,-0.5044002423511389
344,2018-10-10,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",NVS,-0.008109920297264095,-0.21272274978412242,-0.0021112383150854175,-0.0029236756476259673,-0.003960221893843374,-0.01829627385654986,0.012856070124040553,-0.025951095803728008,0.2650663571722507
345,2018-10-12,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",NVS,0.007056056055491533,-0.4980968061907407,-0.025951095803728008,-0.008109920297264095,-0.0021112383150854175,-0.0029236756476259673,-0.003960221893843374,0.004469671909881345,0.1517401213565186
346,2018-10-18,"Earnings Scheduled For October 18, 2018",NVS,0.011256955089818943,0.7567101704035875,-0.005132917232693379,0.030907917602092105,0.004469671909881345,0.007056056055491533,-0.025951095803728008,0.011015914065515275,-0.3800503084689735
347,2018-10-19,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",NVS,0.011015914065515275,-0.3800503084689735,0.011256955089818943,-0.005132917232693379,0.030907917602092105,0.004469671909881345,0.007056056055491533,-0.001032370527812021,-0.16383858161373588
348,2018-10-22,11 Stocks That Moved From ESMO 2018,NVS,-0.001032370527812021,-0.16383858161373588,0.011015914065515275,0.011256955089818943,-0.005132917232693379,0.030907917602092105,0.004469671909881345,0.01044789974746485,0.5275043168775653
349,2018-11-01,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,NVS,0.008460880132683313,-0.42451895361217673,0.009580867798506087,0.006272651440718979,0.009379787026621678,-0.005248487303536886,0.017685636033044627,-0.011337795922943261,-0.24475820175121954
350,2018-11-09,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",NVS,-0.00022414558059247192,0.026236898877167958,0.003824701213683168,0.011146272583259842,-0.014680875845070052,0.02327971543431495,-0.011337795922943261,-0.01109619294233366,-0.2949716239107988
351,2018-11-20,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",NVS,-0.015400316315438367,0.15133935831610246,0.006381706026467704,0.005846039303944117,-0.0010307155352502484,-0.01109716669077132,0.0009066123866647846,0.023922009855381843,0.058573039988215614
352,2018-12-11,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",NVS,0.003682426181685017,-0.0065730310811771275,-0.002066994515456222,-0.022122440812138988,-0.018948990270017063,-0.008086423873224002,-0.0002186501979443145,0.010433287036911265,0.3643249375327007
353,2018-12-19,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",NVS,-0.011008082831030053,0.4172326320596822,-0.004314479340059907,-0.018652053338827357,-0.011425512032680607,0.003063844011011785,0.010433287036911265,-0.0026052062412252885,0.645422104670518
354,2018-12-20,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",NVS,-0.0026052062412252885,0.645422104670518,-0.011008082831030053,-0.004314479340059907,-0.018652053338827357,-0.011425512032680607,0.003063844011011785,-0.010447616276986649,-0.38379880234816643
355,2018-12-21,A Peek Into The Markets: US Stock Futures Down Ahead Of GDP Report,NVS,-0.010447616276986649,-0.38379880234816643,-0.0026052062412252885,-0.011008082831030053,-0.004314479340059907,-0.018652053338827357,-0.011425512032680607,-0.010317874543053662,-0.817241692550667
356,2019-01-08,"The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase",NVS,0.021677611915666528,0.34534962876499087,-0.011759107652621004,0.01357084613372983,0.008089532516564635,-0.020393881721451734,0.006450777770119931,0.0027676711025181877,-0.5779632922855172
357,2019-01-17,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",NVS,0.007731559432044621,0.16567586834904668,0.0009103267224264133,0.012094111075954928,-0.010823709500424439,-0.003858876637874542,0.01322427601269971,0.0040619250656639405,0.44357944203968236
358,2019-01-30,"Earnings Scheduled For January 30, 2019",NVS,-0.010624699348093847,0.26477932655357983,0.010974905148181335,-0.0034904024418676016,-0.0052082755891103005,-0.019852454714118117,-0.0019248507030749096,0.021594214451055915,0.3520704472277698
359,2019-01-30,25 Stocks Moving In Wednesday's Pre-Market Session,NVS,-0.010624699348093847,0.26477932655357983,0.010974905148181335,-0.0034904024418676016,-0.0052082755891103005,-0.019852454714118117,-0.0019248507030749096,0.021594214451055915,0.3520704472277698
360,2019-01-30,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",NVS,-0.010624699348093847,0.26477932655357983,0.010974905148181335,-0.0034904024418676016,-0.0052082755891103005,-0.019852454714118117,-0.0019248507030749096,0.021594214451055915,0.3520704472277698
361,2019-02-01,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,NVS,0.0015997371314016018,-0.07165606090701326,0.021594214451055915,-0.010624699348093847,0.010974905148181335,-0.0034904024418676016,-0.0052082755891103005,0.008213508449566698,-0.34810869065090166
362,2019-02-15,"The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings",NVS,0.009660807816859851,-0.0649807183424117,0.002138979766830751,-0.00022501358080417866,0.008284130734343531,-0.008216067754939438,0.006000799329095363,0.001001243733345314,-0.09697176649304728
363,2019-02-20,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",NVS,0.008558442218580042,-0.33279932272374113,0.001001243733345314,0.009660807816859851,0.002138979766830751,-0.00022501358080417866,0.008284130734343531,-0.00253472303808977,-0.43096134796948116
364,2019-02-26,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",NVS,0.004281034105360737,-0.25991736892682316,0.0035249233422496307,0.0029831651571226026,-0.00253472303808977,0.008558442218580042,0.001001243733345314,-0.0021859945042227436,0.13566347999020523
365,2019-03-04,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,NVS,0.008188901202404564,0.047739739691491145,0.0018633398718830296,-0.0006572237806918846,-0.0021859945042227436,0.004281034105360737,0.0035249233422496307,0.006049706786563247,1.6329154201899203
366,2019-03-05,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",NVS,0.006049706786563247,1.6329154201899203,0.008188901202404564,0.0018633398718830296,-0.0006572237806918846,-0.0021859945042227436,0.004281034105360737,0.00011121595705665399,-0.6734103134453753
367,2019-03-14,Tilray Adds Former Goldman Sachs Managing Director To Senior Management Team,NVS,0.00425635055342366,-0.3483432369461954,0.01731983630585776,0.0,0.004348789155540045,0.002795472532700183,-0.004231068838687957,0.013801345200169957,0.6431795983844915
368,2019-03-22,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",NVS,-0.002562480638916842,-0.24592579498425993,0.0019254274683788708,0.005269394465976962,-0.0019318340987136695,-0.001286375287905095,0.013801345200169957,-0.0011773585324797997,-0.5152668631433575
369,2019-03-27,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",NVS,0.0009471109912231324,-0.10800679042503336,0.018325955654373782,-0.0011773585324797997,-0.002562480638916842,0.0019254274683788708,0.005269394465976962,0.005467485194937671,-0.6091605427233582
370,2019-04-02,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",NVS,-0.00867197332348435,0.04951995040570489,-0.004472623626822658,0.005333005593521234,0.005467485194937671,0.0009471109912231324,0.018325955654373782,0.0008431419477525903,0.9120447063731905
371,2019-04-05,"The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership",NVS,-0.0024410399685880213,-0.21445412683125753,-0.0077928605755642755,0.0008431419477525903,-0.00867197332348435,-0.004472623626822658,0.005333005593521234,0.010001099733516261,0.1451342703853351
372,2019-04-10,Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug,NVS,-0.017743656812842845,-0.4011863193419726,-0.019429557213648474,0.010001099733516261,-0.0024410399685880213,-0.0077928605755642755,0.0008431419477525903,-0.000732409833496761,-0.29994876424232075
373,2019-04-11,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",NVS,-0.000732409833496761,-0.29994876424232075,-0.017743656812842845,-0.019429557213648474,0.010001099733516261,-0.0024410399685880213,-0.0077928605755642755,-0.019909569758568724,0.5496462551841912
374,2019-04-12,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",NVS,-0.019909569758568724,0.5496462551841912,-0.000732409833496761,-0.017743656812842845,-0.019429557213648474,0.010001099733516261,-0.0024410399685880213,0.00897313752188933,-0.421734436847787
375,2019-04-16,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Mediconova, Proteon To Explore Strategic Alternatives",NVS,-0.02000989645385165,0.15934194150591163,0.00897313752188933,-0.019909569758568724,-0.000732409833496761,-0.017743656812842845,-0.019429557213648474,-0.02571213639340475,0.5791874937099533
376,2019-04-24,"Earnings Scheduled For April 24, 2019",NVS,0.025296285512093064,-0.47438265658820733,0.006631367668596733,-0.013218349584775968,-0.01151337322671453,-0.02571213639340475,-0.02000989645385165,0.03572352555171188,-0.23052543067204245
377,2019-04-30,"The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering",NVS,0.013558559630730604,0.32948351933558273,-0.0019682863613053048,0.00856081098543493,0.03572352555171188,0.025296285512093064,0.006631367668596733,-0.0038915721923389324,-0.44182528062469495
378,2019-04-30,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,NVS,0.013558559630730604,0.32948351933558273,-0.0019682863613053048,0.00856081098543493,0.03572352555171188,0.025296285512093064,0.006631367668596733,-0.0038915721923389324,-0.44182528062469495
379,2019-05-22,"The Daily Biotech Pulse: Tocagen Tumbles, OncoSec Offering, Novartis Asthma Combo Drug Study",NVS,0.01844890720444914,0.09360773018675084,0.004633598006021256,-0.008343318491446206,0.0030320632310367746,0.011036132923412545,0.010157315972914027,0.006316176174457011,-0.12102289622360984
380,2019-05-31,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,NVS,-0.0018648250360236984,0.14126373004189796,-0.0001164793845553902,-0.01277037495998945,-0.006855381792904347,0.03647539699210922,0.006316176174457011,0.023587024036328508,0.12090092771741823
381,2019-06-07,Sanofi's Leadership Transition: What You Need To Know,NVS,0.0045631928214386885,0.8098488080003792,0.0013708446876781188,0.0013726240753682006,-0.0027378341034691722,0.023587024036328508,-0.0018648250360236984,0.0018168640435234362,-0.7369192897920704
382,2019-06-12,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",NVS,0.00998872383253313,-0.6516029929141272,-0.0013602781157163735,0.0018168640435234362,0.0045631928214386885,0.0013708446876781188,0.0013726240753682006,0.0068553262911257296,0.25771582989617414
383,2019-07-05,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",NVS,-0.022270173682612193,0.28982508933609186,0.004343111011711365,0.0026126553736758318,0.00602351836291426,0.004068587742133367,-0.0028509494456661066,0.0033169720429324645,-0.20355788859725865
384,2019-07-12,"Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",NVS,-0.02379898679540593,0.2947200566973778,-0.011489260464453754,0.0036241709048803195,0.0035265050456125824,0.0033169720429324645,-0.022270173682612193,0.012246261333592745,-0.16399813887292336
385,2019-07-12,"The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study",NVS,-0.02379898679540593,0.2947200566973778,-0.011489260464453754,0.0036241709048803195,0.0035265050456125824,0.0033169720429324645,-0.022270173682612193,0.012246261333592745,-0.16399813887292336
386,2019-07-18,"Earnings Scheduled For July 18, 2019",NVS,0.04466373245594357,0.41780750339638417,0.01200082743581432,-0.0012322134485321934,0.012246261333592745,-0.02379898679540593,-0.011489260464453754,-0.007426324560705466,-0.3579273236529815
387,2019-09-19,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO",NVS,0.0008113285925355207,-0.36673220053363287,-0.002889097822044051,0.004527472614151318,-0.009771276268841445,-0.02793597132436021,0.006863140246512245,0.008338107111467874,1.1210777248031931
388,2019-09-25,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",NVS,-0.010526427912236902,-0.01785976774952225,-0.0018472817418454524,-0.005283184392314677,0.008338107111467874,0.0008113285925355207,-0.002889097822044051,0.01566523966240596,0.813290428795929
389,2019-09-27,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",NVS,0.005985419351346666,-0.0399488258841979,0.01566523966240596,-0.010526427912236902,-0.0018472817418454524,-0.005283184392314677,0.008338107111467874,-0.005720881965893376,-0.37106134204530805
390,2019-09-30,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,NVS,-0.005720881965893376,-0.37106134204530805,0.005985419351346666,0.01566523966240596,-0.010526427912236902,-0.0018472817418454524,-0.005283184392314677,-0.009896414544288135,0.6016676918870891
391,2019-10-02,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",NVS,-0.01964205705906652,-0.05073824357770762,-0.009896414544288135,-0.005720881965893376,0.005985419351346666,0.01566523966240596,-0.010526427912236902,0.00995849795605852,-0.1391773432231962
392,2019-10-21,Earnings Season Kicks Into Full Gear In Round 3 Of The WeTrader Competition,NVS,-0.0036831845896700965,1.3205141078421527,-0.00401256520892479,0.0026438204191556736,0.0034601605144910508,0.008960861917371998,-0.007736848859009937,0.004736651630070865,0.7623539593249675
393,2019-10-22,"The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug",NVS,0.004736651630070865,0.7623539593249675,-0.0036831845896700965,-0.00401256520892479,0.0026438204191556736,0.0034601605144910508,0.008960861917371998,-0.003909532641647284,-0.5019888037713612
394,2019-10-22,"Earnings Scheduled For October 22, 2019",NVS,0.004736651630070865,0.7623539593249675,-0.0036831845896700965,-0.00401256520892479,0.0026438204191556736,0.0034601605144910508,0.008960861917371998,-0.003909532641647284,-0.5019888037713612
395,2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study",NVS,0.01691214042917699,-0.02081422018348622,-0.00446680217697093,0.000802400684469351,0.007041496968261507,-0.003909532641647284,0.004736651630070865,-0.008824548888215267,0.14686420331439942
396,2019-10-30,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,NVS,-0.008824548888215267,0.14686420331439942,0.01691214042917699,-0.00446680217697093,0.000802400684469351,0.007041496968261507,-0.003909532641647284,-0.0019403845298238132,-0.04227725299974472
397,2019-10-30,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",NVS,-0.008824548888215267,0.14686420331439942,0.01691214042917699,-0.00446680217697093,0.000802400684469351,0.007041496968261507,-0.003909532641647284,-0.0019403845298238132,-0.04227725299974472
398,2019-11-19,Medicines Company Shares Soar On Rumored Buyout Interest From Novartis,NVS,0.0007749521989095509,1.774813652412711,0.0032207999455091674,0.0059211188670380555,-0.0038948288754582228,0.006383465927130461,0.007446870213376533,0.0014381390073794353,-0.5369008907111551
399,2019-11-26,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",NVS,0.008981480067071779,-0.31169713638569807,0.009062678719146788,-0.0005523284550080776,0.0,0.0014381390073794353,0.0007749521989095509,0.0007597968569701408,-0.35506769462203835
400,2019-11-29,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,NVS,0.0011931846888726394,-0.03440484000291566,0.0007597968569701408,0.008981480067071779,0.009062678719146788,-0.0005523284550080776,0.0,-0.009425715476536034,0.3201479580282327
401,2019-12-05,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",NVS,0.0008738037559208323,-0.07457349325784102,0.005932700908719557,-0.004484354481176567,-0.009425715476536034,0.0011931846888726394,0.0007597968569701408,0.004692314303695433,-0.24963773949444534
402,2019-12-06,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",NVS,0.004692314303695433,-0.24963773949444534,0.0008738037559208323,0.005932700908719557,-0.004484354481176567,-0.009425715476536034,0.0011931846888726394,0.0049960785463714075,1.5632442870936596
403,2019-12-11,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",NVS,0.002586191117067038,0.7693392070484582,0.0029179910316292634,0.0049960785463714075,0.004692314303695433,0.0008738037559208323,0.005932700908719557,0.0002149519913328124,-0.5428078212661421
404,2019-12-19,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",NVS,0.010938342633813436,0.16599703954324374,-0.0038457670537487276,0.005802120989236492,0.0008603664397672794,-0.000752218323538778,0.0002149519913328124,0.00021214736664609823,0.011183653729899712
405,2019-12-23,Stocks That Hit 52-Week Highs On Monday,NVS,0.006151253167550275,-0.028696120045435536,0.00021214736664609823,0.010938342633813436,-0.0038457670537487276,0.005802120989236492,0.0008603664397672794,-0.0005270612448370349,-0.7331199606081122
406,2019-12-27,Stocks That Hit 52-Week Highs On Friday,NVS,0.00590657634791425,0.4837075575027383,-0.00010541126563567982,-0.0005270612448370349,0.006151253167550275,0.00021214736664609823,0.010938342633813436,-0.008598093029002385,-0.18436836762941777
407,2020-01-17,Stocks That Hit 52-Week Highs On Friday,NVS,0.00872769989948674,0.2870029838317951,0.005285372002696409,0.0023310908736120517,0.007149549619683171,-0.0015981030788868589,-0.009602015304396971,-0.007713996225246156,0.41084811559821
408,2020-01-29,Stocks That Hit 52-Week Highs On Wednesday,NVS,0.002093366719651879,0.29256408156580127,0.01963724330559158,-0.0018110795285440906,-0.011061891474468677,-0.0030459073964524963,0.00021009699681506788,0.0018800102792198015,-0.41400829980676024
409,2020-01-29,"Earnings Scheduled For January 29, 2020",NVS,0.002093366719651879,0.29256408156580127,0.01963724330559158,-0.0018110795285440906,-0.011061891474468677,-0.0030459073964524963,0.00021009699681506788,0.0018800102792198015,-0.41400829980676024
410,2020-01-29,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",NVS,0.002093366719651879,0.29256408156580127,0.01963724330559158,-0.0018110795285440906,-0.011061891474468677,-0.0030459073964524963,0.00021009699681506788,0.0018800102792198015,-0.41400829980676024
411,2020-02-05,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",NVS,0.013354396132286617,1.2068098720292504,0.009018508260041358,-0.002751101249285459,-0.014699625327974308,0.0018800102792198015,0.002093366719651879,0.0061222963838978295,-0.2693383038210625
412,2020-02-07,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",NVS,-0.011654291427545593,-0.2504251700680272,0.0061222963838978295,0.013354396132286617,0.009018508260041358,-0.002751101249285459,-0.014699625327974308,0.016591767312236883,-0.08300245793155603
413,2020-02-11,Stocks That Hit 52-Week Highs On Tuesday,NVS,0.00831456729111646,0.27993127147766317,0.016591767312236883,-0.011654291427545593,0.0061222963838978295,0.013354396132286617,0.009018508260041358,0.007940567382831887,0.6110186328733287
414,2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",NVS,0.00831456729111646,0.27993127147766317,0.016591767312236883,-0.011654291427545593,0.0061222963838978295,0.013354396132286617,0.009018508260041358,0.007940567382831887,0.6110186328733287
415,2020-02-12,Stocks That Hit 52-Week Highs On Wednesday,NVS,0.007940567382831887,0.6110186328733287,0.00831456729111646,0.016591767312236883,-0.011654291427545593,0.0061222963838978295,0.013354396132286617,-0.012524076166421483,-0.4413372441837211
416,2020-02-12,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",NVS,0.007940567382831887,0.6110186328733287,0.00831456729111646,0.016591767312236883,-0.011654291427545593,0.0061222963838978295,0.013354396132286617,-0.012524076166421483,-0.4413372441837211
417,2020-03-12,Stocks That Hit 52-Week Lows On Thursday,NVS,-0.09824696946351863,1.184905947757216,-0.0330781731402191,0.04284305586312387,-0.049696758530298646,-0.0010488034421504144,-0.020992622434080066,0.07479410925763785,-0.2414778668525619
418,2020-03-13,"Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year",NVS,0.07479410925763785,-0.2414778668525619,-0.09824696946351863,-0.0330781731402191,0.04284305586312387,-0.049696758530298646,-0.0010488034421504144,-0.08127120063858473,0.3528627883466593
419,2020-03-13,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",NVS,0.07479410925763785,-0.2414778668525619,-0.09824696946351863,-0.0330781731402191,0.04284305586312387,-0.049696758530298646,-0.0010488034421504144,-0.08127120063858473,0.3528627883466593
420,2020-03-16,Stocks That Hit 52-Week Lows On Monday,NVS,-0.08127120063858473,0.3528627883466593,0.07479410925763785,-0.09824696946351863,-0.0330781731402191,0.04284305586312387,-0.049696758530298646,0.05209188124996822,-0.37337386637682146
421,2020-03-17,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",NVS,0.05209188124996822,-0.37337386637682146,-0.08127120063858473,0.07479410925763785,-0.09824696946351863,-0.0330781731402191,0.04284305586312387,-0.02586087341605403,0.14415806163102696
422,2020-03-19,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",NVS,0.008004113751016062,0.14243414819025957,-0.02586087341605403,0.05209188124996822,-0.08127120063858473,0.07479410925763785,-0.09824696946351863,-0.0415563066267175,-0.2633685127205623
423,2020-03-24,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",NVS,0.0408944002021574,-0.22525845358604346,-0.024164674783503703,-0.0415563066267175,0.008004113751016062,-0.02586087341605403,0.05209188124996822,0.045269248906982806,0.2592000555999583
424,2020-04-03,"The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO",NVS,0.00047851467064896624,-0.15095341796356299,0.032991458294091336,-0.01843540018721157,0.006715437648459277,0.033047598962920643,-0.0057688136125002565,0.024987931973462718,0.26255864873318746
425,2020-04-28,"Earnings Scheduled For April 28, 2020",NVS,-0.01730088978755917,0.712427674200089,0.006063862375745188,0.010783278324600909,-0.002265027017552601,0.00033992329735377247,-0.016818891584788664,-0.02646539790404001,-0.14705287781211196
426,2020-04-28,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",NVS,-0.01730088978755917,0.712427674200089,0.006063862375745188,0.010783278324600909,-0.002265027017552601,0.00033992329735377247,-0.016818891584788664,-0.02646539790404001,-0.14705287781211196
427,2020-04-29,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",NVS,-0.02646539790404001,-0.14705287781211196,-0.01730088978755917,0.006063862375745188,0.010783278324600909,-0.002265027017552601,0.00033992329735377247,-0.011433742191730656,-0.26080920941256136
428,2020-05-01,"The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO",NVS,-0.015578962073173774,-0.3579149871747893,-0.011433742191730656,-0.02646539790404001,-0.01730088978755917,0.006063862375745188,0.010783278324600909,0.007073471157884814,0.14053359965758316
429,2020-06-04,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",NVS,-0.006767787866543196,0.07419335599689858,-0.008790234443170952,-0.0025380650033670626,-0.00857824865583423,0.013328697820989222,0.021669684191191863,0.00904608197034995,-0.14868691355282881
430,2020-06-05,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",NVS,0.00904608197034995,-0.14868691355282881,-0.006767787866543196,-0.008790234443170952,-0.0025380650033670626,-0.00857824865583423,0.013328697820989222,-0.0025615100916587252,0.2758103437031241
431,2020-06-17,"The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked",NVS,0.03146611857380499,0.6620366663998078,0.01878793220297781,0.009603022826867535,-0.0005925503430137535,-0.04090898574412205,-0.00486270212642248,0.0018998113877819467,-0.4635726499843452
432,2020-06-30,"The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test",NVS,0.00011449444331490533,0.254515050167224,0.0026407223937241486,-0.027901901878963242,0.009008995880369408,-0.01835064235402295,-0.0017654980646637508,0.0058392395594553115,-0.1996800853105839
433,2020-07-02,"The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts",NVS,-0.003187261324887669,-0.0830279813457695,0.0058392395594553115,0.00011449444331490533,0.0026407223937241486,-0.027901901878963242,0.009008995880369408,0.010163260605476676,-0.05249296158387062
434,2020-07-07,"The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold",NVS,-0.007460884531542811,-0.039106680724623755,0.010163260605476676,-0.003187261324887669,0.0058392395594553115,0.00011449444331490533,0.0026407223937241486,0.0036446023392191496,-0.1456359102244389
435,2020-07-15,"The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent",NVS,0.004573039777437282,-0.12635799275737192,0.016147634715625747,-0.0106884322013312,-0.0037782791864930942,-0.008851580533787096,0.0036446023392191496,-0.005462647104592766,-0.3437453737971873
436,2020-07-16,"The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO",NVS,-0.005462647104592766,-0.3437453737971873,0.004573039777437282,0.016147634715625747,-0.0106884322013312,-0.0037782791864930942,-0.008851580533787096,0.008925521702681571,0.40175953079178894
437,2020-07-21,"Earnings Scheduled For July 21, 2020",NVS,-0.022611098689291675,0.3137254901960784,-0.0018146541985918363,0.008925521702681571,-0.005462647104592766,0.004573039777437282,0.016147634715625747,0.005580230658894569,0.048730374103508334
438,2020-09-17,"The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO",NVS,0.01246525999136816,-0.6369351603714752,-0.012637362741542035,0.010774235321749037,0.0016688835901144117,0.015363867058556746,0.0034004747736757768,-0.0003298342890909467,0.05654333596397576
439,2020-09-24,Gilead Settles US Kickback Allegations For $97M,NVS,-0.013150273891694764,0.02033963969781105,-0.016531767287777832,-0.006480440357633954,-0.015834613309609336,-0.0003298342890909467,0.01246525999136816,0.009385836034672801,-0.34533603341349195
440,2020-10-01,"October FDA, CDC Meetings On Coronavirus Vaccines Set Stage For Emergency Use Authorization",NVS,0.0039098703019502246,-0.26587716676628814,-0.0009191064418032635,-0.00011486272071437043,-0.000688800655940236,0.009385836034672801,-0.013150273891694764,0.002519842063940292,-0.13042593252251788
441,2020-10-21,A Peek Into The Markets: US Stock Futures Edge Higher; Netflix Profit Misses Views,NVS,-0.018088502549618357,-0.1534391534391535,-0.0011655977411678675,-0.00464095321411484,0.009368765400379786,-0.023332915283294398,0.0,0.0032089626613196476,-0.14217105263157892
442,2020-10-27,"Earnings Scheduled For October 27, 2020",NVS,-0.038370166207316925,1.153272223406523,-0.002960984144562362,0.00023691032147143964,0.0032089626613196476,-0.018088502549618357,-0.0011655977411678675,-0.03199494928772406,-0.5120532620532621
443,2020-10-27,"The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings",NVS,-0.038370166207316925,1.153272223406523,-0.002960984144562362,0.00023691032147143964,0.0032089626613196476,-0.018088502549618357,-0.0011655977411678675,-0.03199494928772406,-0.5120532620532621
444,2020-10-28,"A Peek Into The Markets: US Stock Futures Tumble; GE, Ford Earnings In Focus",NVS,-0.03199494928772406,-0.5120532620532621,-0.038370166207316925,-0.002960984144562362,0.00023691032147143964,0.0032089626613196476,-0.018088502549618357,-0.0037010838361490883,-0.16860258686279483
445,2020-10-28,Novartis Strikes Deal To Commercialize Molecular Partners' COVID-19 Drug Candidates,NVS,-0.03199494928772406,-0.5120532620532621,-0.038370166207316925,-0.002960984144562362,0.00023691032147143964,0.0032089626613196476,-0.018088502549618357,-0.0037010838361490883,-0.16860258686279483
446,2020-10-28,"The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts",NVS,-0.03199494928772406,-0.5120532620532621,-0.038370166207316925,-0.002960984144562362,0.00023691032147143964,0.0032089626613196476,-0.018088502549618357,-0.0037010838361490883,-0.16860258686279483
447,2020-10-29,"The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal",NVS,-0.0037010838361490883,-0.16860258686279483,-0.03199494928772406,-0.038370166207316925,-0.002960984144562362,0.00023691032147143964,0.0032089626613196476,0.000128185322382679,-0.10450857177719475
448,2020-11-05,"The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping",NVS,0.0056113179706680505,-0.48978400467016925,0.033436184315147166,0.016046264669547172,0.021644300826534568,0.000128185322382679,-0.0037010838361490883,0.005817320943287463,0.2942219679633866
449,2020-12-16,"The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal",NVS,0.01111482412843312,0.010764766451371255,-0.006405294204795076,-0.022349402432780274,0.010253046300607416,0.0007641111477545426,0.004385620175044513,0.011102555988137697,-0.22439340618633086
450,2020-12-18,"The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data",NVS,-0.011633067779978634,0.9168358208955223,0.011102555988137697,0.01111482412843312,-0.006405294204795076,-0.022349402432780274,0.010253046300607416,-0.026949724385690876,0.0273149157504593
451,2020-12-23,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",NVS,0.002268011402475789,-0.32299180614889,-0.0031651853215761694,-0.026949724385690876,-0.011633067779978634,0.011102555988137697,0.01111482412843312,0.0019236718030632982,-0.42350263784007447
452,2021-01-12,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",NVS,-0.005720989654252717,0.2577609972431978,0.003721832598446495,0.006852164531754079,-0.0011762036898050887,-0.011626741706533883,0.0025431500870845003,-0.00575390770067985,0.26735598227474155
453,2021-01-19,"Piclidenoson From Can-Fite Biopharma Shows New, Promising Developments For Psoriasis Treatment",NVS,0.011084502211397451,-0.05345285524568388,0.010674088408998195,0.014039389692569904,-0.00575390770067985,-0.005720989654252717,0.003721832598446495,0.0023787183758046115,-0.21948439144159948
454,2021-01-26,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",NVS,-0.025693001655329506,0.4523439523439523,0.016202195537095676,0.00020650524469001397,-0.0004127510063753892,0.0023787183758046115,0.011084502211397451,-0.031686533526737004,0.1347302719572001
455,2021-01-26,"Earnings Scheduled For January 26, 2021",NVS,-0.025693001655329506,0.4523439523439523,0.016202195537095676,0.00020650524469001397,-0.0004127510063753892,0.0023787183758046115,0.011084502211397451,-0.031686533526737004,0.1347302719572001
456,2021-02-04,"The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs",NVS,0.01443932393874392,-0.19884668118396642,-0.0031244088848843,-0.001559623821848266,-0.007847917525490078,-0.02552770324731457,-0.0006459639972579145,-0.0011033501445654181,-0.2110535058136609
457,2021-02-17,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",NVS,-0.014979126511132534,0.47981091195587955,-0.006193639274671758,-0.0017355251020881868,0.007871337022852698,-0.0012010856684008253,0.006373619831163024,-0.007770128084874761,-0.2062646967478593
458,2021-03-17,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",NVS,-0.004301812105441449,-0.02881060341820718,0.008441887821151184,0.01378811894092502,-0.007198509733771119,0.006532854363089813,0.0077806636603183765,-0.005371320884898445,-0.15708949863525357
459,2021-03-23,"The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO",NVS,-0.0028898098560531382,0.10398673391833069,0.006632516762252516,0.00892222564002787,-0.005371320884898445,-0.004301812105441449,0.008441887821151184,-0.0027823191961274807,-0.13318312679934907
460,2021-03-30,"The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings",NVS,-0.0037778553449635544,0.08588917936619267,-0.0006865233706884188,0.0022933105482774163,0.01383402849150528,-0.0027823191961274807,-0.0028898098560531382,-0.017697038369604012,0.37991779213153265
461,2021-04-27,"Earnings Scheduled For April 27, 2021",NVS,-0.013324193677579865,0.6528892224210587,-0.005211283434057301,0.0004533032760609679,-0.004850077376340467,0.009450155270763538,-0.006223139010591239,0.0020775871881548724,-0.39932944504592605
462,2021-04-27,"Eli LilÂ­ly AbanÂ­dons IL-23 Psoriasis Program, Instead Will Focus On Ulcerative Colitis, Crohn's Disease Indications",NVS,-0.013324193677579865,0.6528892224210587,-0.005211283434057301,0.0004533032760609679,-0.004850077376340467,0.009450155270763538,-0.006223139010591239,0.0020775871881548724,-0.39932944504592605
463,2021-04-27,"The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout",NVS,-0.013324193677579865,0.6528892224210587,-0.005211283434057301,0.0004533032760609679,-0.004850077376340467,0.009450155270763538,-0.006223139010591239,0.0020775871881548724,-0.39932944504592605
464,2021-05-11,Cannabis Industry Salary Report: Increased Demand For Top Talent As Salaries Continue To Surge,NVS,-0.006478728056799166,0.0328833918059106,0.00022744166691723855,0.006983420583756894,0.009826450420001409,0.0101601123595505,-0.008797355512820682,0.0018304126911650176,0.19585492227979273
465,2021-05-17,Supreme Court Rebuffs Novartis Appeal Over Amgen's Arthritis Drug Enbrel: Report,NVS,-0.004608650688146199,-0.12411807868149238,0.006334792210821449,0.009478118606385255,0.0018304126911650176,-0.006478728056799166,0.00022744166691723855,0.0016938845932934488,0.028805258409588808
466,2021-05-27,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-term Migraine Drug Data, Decision Day For Eton, 2 IPOs",NVS,-0.007626705226875474,0.23247688289687307,0.007685318888613457,0.00522617893394095,-0.0010215567104706613,0.001933127702721693,0.0031942288717641265,-0.0011302435821625156,-0.5120701010853068
467,2021-06-04,"The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact",NVS,0.005486510976690395,-0.15069922771863908,0.0047249973710099535,0.008738063110210081,-0.0029418458259564684,-0.0011302435821625156,-0.007626705226875474,-0.0014477094620568565,0.6174735807323666
468,2021-06-07,"The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck",NVS,-0.0014477094620568565,0.6174735807323666,0.005486510976690395,0.0047249973710099535,0.008738063110210081,-0.0029418458259564684,-0.0011302435821625156,0.00022310436215278173,0.2595532933221909
469,2021-06-14,"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings",NVS,0.009709721318434728,-0.1580778430093499,-0.008663027421018432,0.013769937420248679,0.028319703452056588,0.00022310436215278173,-0.0014477094620568565,0.0034191798789404704,0.46943870523415976
470,2021-07-15,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",NVS,-0.013086746838585017,0.24904094574493074,-0.0022661325113355613,-0.0033341195251876954,0.0025880004675697954,0.004223024934258746,0.004459453229824328,0.004931474824018345,0.5243825999749279
471,2021-07-21,"The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay",NVS,0.0026596062466555104,0.13120074177097818,-0.004193354318257958,-0.011777495513453529,0.004931474824018345,-0.013086746838585017,-0.0022661325113355613,0.006631287090665516,-0.019717668488160256
472,2021-07-21,"Earnings Scheduled For July 21, 2021",NVS,0.0026596062466555104,0.13120074177097818,-0.004193354318257958,-0.011777495513453529,0.004931474824018345,-0.013086746838585017,-0.0022661325113355613,0.006631287090665516,-0.019717668488160256
473,2021-07-21,A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings,NVS,0.0026596062466555104,0.13120074177097818,-0.004193354318257958,-0.011777495513453529,0.004931474824018345,-0.013086746838585017,-0.0022661325113355613,0.006631287090665516,-0.019717668488160256
474,2021-08-11,WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19,NVS,0.0023842753606122535,-0.23405000656828834,0.005010346826940015,0.00536575011646212,-0.010081330549337464,0.0072061129977996075,-0.012080765437813445,0.004108571386551185,-0.3294648982391951
475,2021-08-25,"The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug",NVS,-0.0034725203747297817,-0.010682033803014912,-0.01706663458076141,0.004500125440430214,0.001394896125447742,-0.0025686123155627127,-0.017868326751856234,-0.002940340726907409,-0.2864500088794175
476,2021-08-27,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",NVS,0.0050240276432038655,-0.08043802887008467,-0.002940340726907409,-0.0034725203747297817,-0.01706663458076141,0.004500125440430214,0.001394896125447742,-0.004020853020421433,-0.15865540759987007
477,2021-09-10,ADHD Drug Developer Cingulate Plans NASDAQ Debut,NVS,-0.012255643294207363,-0.2668556579258209,-0.012333043218739514,-0.020907873375945907,-0.021444214895157354,-0.008138910895919227,-0.005396599288403081,-0.0019899245506358465,-0.0420184313978218
478,2021-09-21,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",NVS,0.003019393054113806,-0.3121454545454545,-0.008145727092458754,-0.01066596522227703,-0.008227583403280891,-0.0023452112435922157,0.00023454694596725112,-0.0030103037638384844,0.09769507295411284
479,2021-10-06,"Cannabis Movers & Shakers: TOCC, 1933 Industries, Iter Investments, Greenlane",NVS,-0.0004888578818273981,-0.20273499734466283,-0.007519664551536742,0.005365128183863366,0.0028124231413844125,-0.01339120073422606,0.007168844927381901,0.008436238405115981,0.5800721620871496
480,2021-10-19,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",NVS,0.009837276668545947,0.029165856503986065,-0.01188051679849933,0.008837810763827614,0.0020623469540537176,0.005489107681573957,-0.004372067001627178,0.015874914301737153,0.437244158952075
481,2021-10-26,"The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children",NVS,0.01775436535981889,0.6769267477928895,-0.018370254958807508,0.002952609544155438,0.0023676999885606786,0.015874914301737153,0.009837276668545947,-0.024870282343284478,0.007313602731929381
482,2021-10-26,"Earnings Scheduled For October 26, 2021",NVS,0.01775436535981889,0.6769267477928895,-0.018370254958807508,0.002952609544155438,0.0023676999885606786,0.015874914301737153,0.009837276668545947,-0.024870282343284478,0.007313602731929381
483,2021-11-03,"This Company Wants to Revolutionize What Matters for Hospitals, Big Pharma and Health Insurers",NVS,-0.0019105035406361548,-0.015860614110477345,-0.0035692480401898763,0.015587124406655883,-0.006601761458675637,0.007010673965913705,-0.024870282343284478,0.001196461973237417,0.20554144172753253
484,2021-11-04,"The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO",NVS,0.001196461973237417,0.20554144172753253,-0.0019105035406361548,-0.0035692480401898763,0.015587124406655883,-0.006601761458675637,0.007010673965913705,-0.0004779930436799029,-0.21185380309515967
485,2021-11-09,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",NVS,-0.0015622759055993196,-0.09206164322193355,-0.005140461119480855,-0.0004779930436799029,0.001196461973237417,-0.0019105035406361548,-0.0035692480401898763,0.0009628895230513468,0.23797305965362403
486,2021-11-23,Novartis May Have Buyer(s) For Its Sandoz Unit - Report,NVS,0.01660097313798503,0.24476581048996326,-0.004163586957791399,-0.0037818489866972005,0.0008546434666258929,-0.0001220191629829337,-0.004496826495923867,-0.009193120545168076,-0.2217357378186232
487,2021-12-02,"The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance",NVS,0.0016286145699124788,-0.0490813201769309,0.001505664088090386,-0.0071010153061071835,-0.005328371711354585,-0.014772318317516797,-0.009193120545168076,0.0006253637494437747,0.05765274174792023
488,2021-12-06,"The Week Ahead In Biotech (Dec. 6-Dec. 11): DarÃ© FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",NVS,0.006625044659436474,-0.019917959994925405,0.0006253637494437747,0.0016286145699124788,0.001505664088090386,-0.0071010153061071835,-0.005328371711354585,0.0018626820685463397,-0.18130824991370387
489,2021-12-13,How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal,NVS,0.0022313393680875038,0.35383211678832116,0.0028591703178340033,-0.011307664947156182,0.00842832209834632,0.0018626820685463397,0.006625044659436474,-0.0032159384486534215,-0.014638091386979357
490,2021-12-17,"The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More",NVS,-0.001975127996408199,-0.11774944880062332,0.05581454786942075,0.011539928930109689,-0.0032159384486534215,0.0022313393680875038,0.0028591703178340033,-0.006402806030153085,-0.3938932732055618
491,2021-12-22,"The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda",NVS,0.0037213751870768252,-0.24799885648942255,0.007498560286531619,-0.006402806030153085,-0.001975127996408199,0.05581454786942075,0.011539928930109689,0.004055166329761217,0.515016156624216
492,2022-01-31,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",NVS,0.011639968487394903,0.3641841512051327,0.009044100964030521,0.01068379055836055,-0.0035487562772348324,-0.006930529463104906,-0.021831465050623833,0.014612833121022017,0.010168737487686208
493,2022-02-10,"The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly",NVS,-0.015710880907179647,0.6404330963154492,0.00057360339422452,-0.0006880026751644452,0.0107788918830789,-0.0016198868900878516,0.0059362255931785235,-0.003029247648412059,0.024209437493843078
494,2022-03-02,36 Stocks To Watch After Biden's First State of The Union Address,NVS,0.006427865075002925,-0.15795747298804164,-0.003887474530887003,-0.0019399664803020356,0.02275908421941497,-0.009708757409428337,0.008039146070482062,-0.01756382625594788,0.05854148591259878
495,2022-03-08,Stocks That Hit 52-Week Lows On Tuesday,NVS,-0.0009105422745387948,0.4371846539523372,-0.01416093536287355,-0.01625258088473258,-0.01756382625594788,0.006427865075002925,-0.003887474530887003,0.025465054677855203,-0.1197394568337381
496,2022-03-22,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout",NVS,-0.00197488911017063,0.040864604109652536,-0.008180651083880108,0.004049096061062629,0.021266519662193284,-0.00106218244338796,0.007850647085360318,-0.004190464540993477,-0.1266042780748663
497,2022-03-22,"Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22",NVS,-0.00197488911017063,0.040864604109652536,-0.008180651083880108,0.004049096061062629,0.021266519662193284,-0.00106218244338796,0.007850647085360318,-0.004190464540993477,-0.1266042780748663
498,2022-03-24,"The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL",NVS,0.012740987870671017,-0.29639267309556605,-0.004190464540993477,-0.00197488911017063,-0.008180651083880108,0.004049096061062629,0.021266519662193284,0.0025392578824730005,-0.03328498912255262
499,2022-04-01,Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates,NVS,-0.0006837811856659215,0.19877895492907172,-0.002387384818954952,0.00514219616580025,0.005977725402225964,0.0014966909656690675,0.0025392578824730005,-0.004105312803137862,1.4062312762133016
500,2022-04-04,"Morning Brief: Top Stories Dominating Financial Media on Monday, April 4",NVS,-0.004105312803137862,1.4062312762133016,-0.0006837811856659215,-0.002387384818954952,0.00514219616580025,0.005977725402225964,0.0014966909656690675,0.00961861113833229,-0.4427290836653387
501,2022-04-06,"The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy",NVS,0.028127482723024233,0.021373249925528803,0.00961861113833229,-0.004105312803137862,-0.0006837811856659215,-0.002387384818954952,0.00514219616580025,0.008273608523687415,-0.11013488880787459
502,2022-04-26,"Earnings Scheduled For April 26, 2022",NVS,-0.0163645199728778,-0.2260725017581996,0.013787703596498613,-0.00822674459769468,-0.014138567048843642,-0.003930075252858489,-0.007153738107519847,0.005058560441461246,0.11912432878975632
503,2022-04-27,"The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis",NVS,0.005058560441461246,0.11912432878975632,-0.0163645199728778,0.013787703596498613,-0.00822674459769468,-0.014138567048843642,-0.003930075252858489,0.009059348858744265,0.011146379272163554
504,2022-05-16,5 Value Stocks In The Healthcare Sector,NVS,0.023188005972857972,-0.11939350639041046,0.0051534621204682995,0.015944761279013786,-0.004147362494802076,0.010900743980282623,-0.027266354418452043,0.0012527574626013394,-0.02974849003876323
505,2022-05-31,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,NVS,-0.0056855709281480316,0.4355547333857466,0.002191577339877071,0.0001095777878843407,-0.007396952126997203,0.013449477486465744,0.014426335467208284,-0.014295159944593627,-0.5337134757256532
506,2022-07-19,"This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session",NVS,0.039903309393959585,-0.39975848327496677,-0.022920696215794845,0.024697403770857163,-0.004939232062676546,-0.01107934248910769,-0.00650963711225272,-0.020697678702629174,0.01665794873858295
507,2022-07-19,IBM And 20 Stocks Moving Premarket,NVS,0.039903309393959585,-0.39975848327496677,-0.022920696215794845,0.024697403770857163,-0.004939232062676546,-0.01107934248910769,-0.00650963711225272,-0.020697678702629174,0.01665794873858295
508,2022-07-19,"The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings",NVS,0.039903309393959585,-0.39975848327496677,-0.022920696215794845,0.024697403770857163,-0.004939232062676546,-0.01107934248910769,-0.00650963711225272,-0.020697678702629174,0.01665794873858295
509,2022-07-20,Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday,NVS,-0.020697678702629174,0.01665794873858295,0.039903309393959585,-0.022920696215794845,0.024697403770857163,-0.004939232062676546,-0.01107934248910769,0.019829063254611645,-0.0631653935963905
510,2022-08-25,"Benzinga Before The Bell: Twitter Whistleblower Peiter Zatko To Depose Before Senate Panel, GameStop To Boost Employee Compensation To Drive Growth, California Proposes Total Ban On New Gasoline Car Sales By 2035 And Other Top Financial Stories Thursday, August 25",NVS,-0.0023920982585566852,1.5267941677712553,0.0015572900102183151,-0.010783199087738726,-0.015974844238538566,0.009891678549836636,-0.0035203126542834307,-0.008752003842184886,-0.39534622302158273
511,2022-09-01,"Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlashâ€¦",NVS,-0.002359617770790967,0.2754889115349153,-0.0029718572570076596,-0.018115480173033216,-0.005200721686430709,-0.008752003842184886,-0.0023920982585566852,-0.007842636686208548,-0.29360066960888753
512,2022-09-01,Novartis Appoints Merck Executive As Research Head,NVS,-0.002359617770790967,0.2754889115349153,-0.0029718572570076596,-0.018115480173033216,-0.005200721686430709,-0.008752003842184886,-0.0023920982585566852,-0.007842636686208548,-0.29360066960888753
513,2022-09-15,"Top Financial Media Stories Thursday, September 15: US Railway Companies, Unions Reach Tentative Agreement, Tesla To Wind Down Stores In China's Flashy Malls, Netflix Could Face Legal Action Over South Korean Crime Drama And More..",NVS,-0.002101179336714165,-0.22045825592523782,-0.012690624818765373,-0.019736815792576023,0.012106547798325318,0.016490250510810656,0.003953533295800504,-0.0011146733109939078,0.17433379071278976
514,2022-09-21,"Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More..",NVS,-0.02563464890671774,0.25343633457645187,-0.014245029697073086,0.0009920360726032307,-0.0011146733109939078,-0.002101179336714165,-0.012690624818765373,-0.0051586115188216874,0.6799846984315892
515,2022-09-22,"Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..",NVS,-0.0051586115188216874,0.6799846984315892,-0.02563464890671774,-0.014245029697073086,0.0009920360726032307,-0.0011146733109939078,-0.002101179336714165,-0.014648631305213433,-0.30760278304870337
516,2022-09-23,Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings,NVS,-0.014648631305213433,-0.30760278304870337,-0.0051586115188216874,-0.02563464890671774,-0.014245029697073086,0.0009920360726032307,-0.0011146733109939078,-0.018418726670763275,-0.14075346219899876
517,2022-10-14,"Biden Asked OPEC+ To Delay Output Decision, Elon Musk Faces Federal Probe Over Twitter Deal, Netflix Ad-Supported Plan: Top Stories Friday, Oct. 14",NVS,-0.005788745660404548,0.05079814103859359,0.009295017382306092,-0.007250292397047109,0.004103242815768793,-0.0013218465315235628,-0.0051288762464528626,0.022495601031838897,-0.18413968156295668
518,2022-10-25,US Stock Futures Down; Big Tech Earnings In Focus,NVS,0.010294755515051213,-0.047735286140493605,0.007911816861842835,0.020516108705376235,-0.012547339444405559,-0.01264672798531874,0.0028471762317090477,0.01401093443849244,-0.17292590633519145
519,2022-12-02,"Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors",NVS,0.0018926572450377321,0.29511303641532427,0.0029030503495544036,0.02518311542589302,-0.0036496234385071658,-0.00034200114417903826,0.004811509610342268,0.010779019354729025,-0.025974704714121444
520,2022-12-13,"A Career Politician Who Regularly Trades The SPY, Picked Up These 3 High Yielding ETFs Instead",NVS,0.003631139570941855,-0.15845752294350424,-0.000769662163563889,-0.006879220461647351,-0.0016353261695927213,0.010910401492738142,-0.0024186598182753816,0.014472095683115693,0.14422211105552774
521,2022-12-20,"Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says",NVS,0.0019957581533032176,0.12002271275463117,-0.003205063061707647,-0.004510922175753329,-0.017723968961093517,0.014472095683115693,0.003631139570941855,0.0058647923762191745,-0.06888466413181238
522,2022-12-29,"Elon Musk Tells Employees Tesla Will Be 'Most Valuable Company On Earth, Sam Bankman-Fried Set To Enter Plea On Fraud Case, Twitter 'Should Feel Faster': Today's Top Stories",NVS,0.008366376222265659,-0.13059461982844134,-0.0031822898771854957,0.002861199371603229,-0.00033008667818690274,0.0,0.0058647923762191745,-0.009606956841568315,0.4006309148264984
523,2022-12-29,Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug,NVS,0.008366376222265659,-0.13059461982844134,-0.0031822898771854957,0.002861199371603229,-0.00033008667818690274,0.0,0.0058647923762191745,-0.009606956841568315,0.4006309148264984
524,2023-01-19,Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide,NVS,0.0007595569812426373,-0.4135685586292892,-0.00238139577851626,0.014495935151259243,0.005521161963461196,0.0009947907459206817,0.0003316775569517372,-0.0017347878920126458,0.1337218459599936
525,2023-01-19,"Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects",NVS,0.0007595569812426373,-0.4135685586292892,-0.00238139577851626,0.014495935151259243,0.005521161963461196,0.0009947907459206817,0.0003316775569517372,-0.0017347878920126458,0.1337218459599936
526,2023-02-02,"Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?",NVS,-0.024141496040811283,-0.040539659779704085,-0.026373883745125726,0.010932651506135871,0.0016761707797583458,-0.0038957694694100597,-0.032000921588388076,,
